FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acrivastine and Pseudoephedrine Hydrochloride Capsules
Status: Discontinuation
»Therapeutic Categories: Pulmonary/Allergy

Endo Pharmaceuticals, Inc. (New 06/02/2020)

Company Contact Information:
800-462-3636

Presentation Posting Date Related Information
Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10) 06/02/2020 Endo has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English